As you know, the LITFL Critical Care Compendium is a living resource built around the knowledge base needed for the FCICM exam, but extends far beyond those conservative boundaries. Plugging away on this project is where I spend most of my time ‘living in the fast lane’.
Here is what is new or undergone a major overhaul recently:
- A problem that may be trivial, or life-threatening – as is the treatment!
- Few areas of medicine are funkier than haemolytic anaemia. The myriad causes, investigations and potential complications (respect cold agglutination is all I can say…) might even cause a bead of sweat to form on Dr. House’s furrowed brow. Here is my distillation of this challenging critical care problem.
- This page may be biased, as I think in situ simulation is the greatest thing since the laryngoscope blade bottle opener. The pros, the cons, the safety issues, how to ensure success and the evidence – it is all here.
- Based on a clinical update by James Hayes, this page outlines the clinical issues regarding the new oral anticoagulant rivaroxaban, an orally active Factor IXa inhibitor.
- Statins have pleiotropic effects and are being studied for numerous conditions in intensive care. Here is another excellent ‘critical evaluation’ of a putative therapy for the critically ill by Sarah Yong.
- Vitamin D also has pleiotropic (the word of the day) effects and is often low in the critically ill. So should we be replacing it? Could this be a future ‘critically evaluate’ question in the FCICM Part II exam? This is a great overview by Sarah Yong.